Pathologic T cell immunosenescence drives the development of age-associated autoimmune peripheral neuropathy

preprint OA: closed
Full text JSON View at publisher

Abstract

While certain autoimmune conditions occur commonly in the young, others are more frequent in the aged. A striking example is chronic inflammatory demyelinating polyneuropathy (CIDP), an autoimmune disease of peripheral nerves that occurs at a peak decade of onset of 70-79 years. How aging predisposes to autoimmunity, however, remains unclear. In CIDP patients, we identified an expanded population of T cells that exhibit hallmark senescence features, including increased SA-βGal activity and higher CDKN1A expression. These senescence associated T cells express multiple senescence associated secretory phenotype (SASP) factors (IFN-γ, TNF-α, TGF-β, IL21, Spp1) and demonstrated an enhanced capacity for inciting neuropathy in a CIDP mouse model. Notably, SASP suppression by a clinically available senomorphic therapy dampened senescence features in peripheral nerves and protected mice against neuropathy. Together, these findings delineate a key role for T cells exhibiting a pro-inflammatory SASP in predisposing to age-associated autoimmune disease.
Full text 1,144 characters · extracted from oa-doi-fallback · click to expand
Abstract While certain autoimmune conditions occur commonly in the young, others are more frequent in the aged. A striking example is chronic inflammatory demyelinating polyneuropathy (CIDP), an autoimmune disease of peripheral nerves that occurs at a peak decade of onset of 70-79 years. How aging predisposes to autoimmunity, however, remains unclear. In CIDP patients, we identified an expanded population of T cells that exhibit hallmark senescence features, including increased SA-βGal activity and higher CDKN1A expression. These senescence associated T cells express multiple senescence associated secretory phenotype (SASP) factors (IFN-γ, TNF-α, TGF-β, IL21, Spp1) and demonstrated an enhanced capacity for inciting neuropathy in a CIDP mouse model. Notably, SASP suppression by a clinically available senomorphic therapy dampened senescence features in peripheral nerves and protected mice against neuropathy. Together, these findings delineate a key role for T cells exhibiting a pro-inflammatory SASP in predisposing to age-associated autoimmune disease. Competing Interest Statement The authors have declared no competing interest.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00